• αKG–Carnitine Pathway Regulates Histone Acetylation for DNA

  2026-07-03

  This study reveals that α-ketoglutarate (αKG)-mediated carnitine synthesis is essential for histone acetylation and homologous recombination (HR) proficiency in cancer cells. The findings uncover a metabolic mechanism controlling DNA repair resistance and suggest new targets to sensitize HR-proficient tumors to DNA-damaging agents.

• Docosahexaenoic Acid (DHA): Reliable Solutions for Neuroprot

  2026-07-03

  This article addresses prevalent laboratory challenges in cell viability and neuroprotection workflows, showcasing how Docosahexaenoic Acid (DHA, SKU C4188) from APExBIO delivers reproducible, data-driven solutions. Through scenario-based Q&A and literature-backed insights, researchers gain actionable guidance for assay optimization and reliable experimental outcomes.

• Parathyroid hormone (1-34) (human): Mechanisms & Benchmarks

  2026-07-02

  Parathyroid hormone (1-34) (human) is a potent PTH1R agonist essential for bone metabolism and serum calcium regulation in research models. The A1129 peptide fragment from APExBIO is validated for high-fidelity signaling and precise protocol integration in osteoporosis and chronic kidney disease studies.

• DiR (DiIC 18 (7)) for High-Fidelity Membrane Tracking & EV A

  2026-07-02

  Explore the science and protocols behind DiR (DiIC 18 (7)), the deep-red fluorescent dye redefining cell membrane staining and long-term extracellular vesicle (EV) imaging. This article provides an advanced analysis and cross-study insights for optimizing live and fixed membrane assays.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Precision Δ

  2026-07-01

  The JC-1 Mitochondrial Membrane Potential Assay Kit enables reproducible, ratiometric quantification of mitochondrial membrane potential, empowering researchers with sensitive detection of early apoptosis and mitochondrial dysfunction. Its robust protocol and built-in positive control streamline experiments in oncology, immunotherapy, and beyond.

• PP2A-Regulated Autophagy Drives Candida albicans Drug Resist

  2026-07-01

  This study demonstrates that protein phosphatase 2A (PP2A) modulates Candida albicans biofilm drug resistance through autophagy induction and ATG protein phosphorylation. The mechanistic link identified offers new insight for antifungal resistance research and highlights autophagy as a promising target for future therapeutic strategies.

• Ganetespib (STA-9090): Redefining Hsp90 Inhibition in Cancer

  2026-06-30

  This thought-leadership article unpacks how Ganetespib (STA-9090) is advancing the strategic edge of cancer research through potent Hsp90 chaperone disruption, drawing mechanistic inspiration from recent virology findings on regulated cell death and selective protein secretion. With a focus on translational scientists, we bridge the latest mechanistic insights, competitive landscape analysis, and protocol guidance to illuminate new research pathways and maximize experimental rigor.

• Moesin as a Novel Biomarker of Endothelial Injury in Sepsis

  2026-06-30

  This article analyzes the discovery that moesin (MSN) serves as a sensitive biomarker for endothelial injury in sepsis, linking its expression to disease severity and mechanistic pathways of vascular dysfunction. The findings provide actionable insight for researchers studying sepsis pathogenesis, endothelial permeability, and the evaluation of new therapeutic or diagnostic strategies.

• WAY-100635 in Neural Pathway Dissection: Beyond Antagonism

  2026-06-29

  Explore the multifaceted utility of WAY-100635 as a serotonin 5-HT1A receptor antagonist in advanced neuroscience receptor pharmacology. This article uniquely bridges mechanistic insights with translational pain and affective research, offering a deeper look at serotonergic modulation in complex behavioral models.

• Fluconazole (SKU B2094): Reliable Antifungal for Research As

  2026-06-29

  This article addresses key laboratory challenges in antifungal susceptibility testing and fungal pathogenesis research using Fluconazole (SKU B2094). Scenario-based Q&A blocks offer practical, evidence-backed guidance for scientists, emphasizing experimental reliability, protocol optimization, and the value of choosing validated reagents like Fluconazole from APExBIO.

• PK/PD Evaluation of Cefazedone for Community-Acquired Pneumo

  2026-06-28

  This article reviews a pharmacokinetic and pharmacodynamic study evaluating intravenous cefazedone sodium for treating community-acquired pneumonia (CAP). The findings demonstrate the clinical rationality of the standard dosing regimen, emphasizing the importance of time-dependent antibiotic exposure for optimal therapeutic outcomes.

• Biotin-XX Tyramide Reagent: Precision in Cell Surface Detect

  2026-06-27

  Biotin-XX Tyramide Reagent delivers unmatched specificity for membrane-impermeant cell surface protein labeling, making it ideal for high-sensitivity tyramide signal amplification in immunohistochemistry and in situ hybridization. Its robust performance, supported by recent advances in stem cell migration research, enables reproducible and selective profiling of cell surface proteomes.

• AMPK–SQSTM1 Feedback Enhances Dual Antioxidant Pathways in S

  2026-06-26

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, driving dual activation of AMPK and NFE2L2/NRF2 to strengthen antioxidant defenses. The mechanistic insights clarify how cancer cells adapt to metabolic and oxidative challenges, illuminating new therapeutic angles for tumors with STK11 and KEAP1 mutations.

• Fluconazole in Translational Antifungal Research: Beyond the

  2026-06-26

  This thought-leadership article explores the mechanistic and translational applications of Fluconazole—a fungal cytochrome P450 enzyme 14α-demethylase inhibitor—in the context of antifungal drug resistance and host-pathogen interplay. By integrating evidence from recent research on mucosal immunity and referencing advanced workflow guides, it provides strategic guidance for researchers seeking to leverage Fluconazole for robust, reproducible, and clinically relevant insights.

• HBsAg Manipulates TBK1 to Suppress Interferon and Induce Aut

  2026-06-25

  The reference study reveals that hepatitis B surface antigen (HBsAg) directly interacts with TANK-binding kinase 1 (TBK1), suppressing type I interferon production and triggering incomplete autophagy in hepatocytes. These findings clarify a crucial mechanism by which HBV evades innate immune responses, offering new molecular targets for therapeutic intervention in chronic hepatitis B.

16659 records 1/1111 page Next 12345 下5页 Last page